bpc-157 safety data human Is BPC‑157 a Risk? Safety, Side Effects, and Concerns Explained FDA advisory committee votes to

V., Abramovitz, L., et al

Yes, but the total systemic dose from all routes should not exceed 6 mg/kg within 24 hours

BPC 157 accelerated parenterally or per-orally the healing of colonic and skin defect, leading to the suitable closure of the fistula, macro/microscopically, biomechanically, and functionally (larger water volume sustained without fistula leaking) ( c, b ): in control rats, drinking water was continuously given (12 ml/day/rat) (defecation through fistula, c ) and in BPC 157 rats, BPC 157 (10 g/kg/day) was given in drinking water (0.16 g/ml/day/rat) (fistula closed, b )

Or use as directed by a veterinary doctor

10.1016/j.addicn.2024.100167 Addict

No elevation of IGF-1 Growth hormone works partly through stimulating insulin-like growth factor 1 (IGF-1) production in the liver